The Effect of Weekly 50,000 IU Vitamin D3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm: A Randomized Clinical Trial in Adults with Vitamin D Deficiency

Nutrients. 2023 Feb 27;15(5):1188. doi: 10.3390/nu15051188.

Abstract

This research aimed to evaluate the effects of high-dose cholecalciferol (VD3) supplements (50,000 IU/week) on selected circulating cytokines associated with cytokine storms in adults with vitamin D deficiency. This clinical trial, based in Jordan, included 50 participants receiving vitamin D3 supplements (50,000 IU/week) for 8 weeks; the exact number was assigned to the control group. Interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-10 (IL-10), tumor necrotic factor-α (TNF-α), and leptin were measured in serum at baseline and 10 weeks (wash out: 2 weeks). Our results revealed that vitamin D3 supplementation significantly increased the serum levels of 25OHD, IL-6, IL-10, IL-1β, and leptin compared with baseline. In contrast, the serum level of TNF-α insignificantly increased in the group receiving vitamin D3 supplementation. Although the observations of this trial may refer to a potential negative effect of VD3 supplementation during cytokine storms, further trials are required to clarify the potential benefits of VD3 supplement during cytokine storms.

Keywords: TNF-α; cytokine; interleukin 10; interleukin 1β; interleukin 6; storm; vitamin D deficiency; vitamin D3.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Cholecalciferol*
  • Cytokine Release Syndrome
  • Cytokines
  • Dietary Supplements
  • Double-Blind Method
  • Humans
  • Interleukin-10
  • Interleukin-6
  • Leptin
  • Tumor Necrosis Factor-alpha
  • Vitamin D
  • Vitamin D Deficiency*

Substances

  • Cholecalciferol
  • Interleukin-10
  • Cytokines
  • Leptin
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Vitamin D

Grants and funding

This research was funded by ASU, Amman, Jordan.